Galectin Therapeutics Inc.GALTNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+90.3%
5Y CAGR+141.3%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+90.3%/yr
vs +32.4%/yr prior
5Y CAGR
+141.3%/yr
Recent deceleration
Acceleration
+57.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
81.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$7.12M+28.4%
2024$5.54M+98.4%
2023$2.79M+170.3%
2022$1.03M+111.2%
2021$489000.00+462.1%
2020$87000.000.0%
2019$87000.00-74.1%
2018$336000.00+2700.0%
2017$12000.00-
2016$0.00-